These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
223 related items for PubMed ID: 2807787
21. Treatment with beta-lactam antibiotics in skin and soft tissue infections. Hedström SA. Scand J Infect Dis Suppl; 1984; 42():135-42. PubMed ID: 6597559 [Abstract] [Full Text] [Related]
24. [Biochemical aspects of beta-lactam antibiotics]. Gröger D. Pharmazie; 1977 Jun 06; 32(6):309-17. PubMed ID: 896931 [No Abstract] [Full Text] [Related]
25. Comparison of ciprofloxacin and beta-lactam antibiotics in the treatment of urinary tract infections and alteration of fecal flora. Daikos GL, Kathpalia SB, Sharifi R, Lolans VT, Jackson GG. Am J Med; 1987 Apr 27; 82(4A):290-4. PubMed ID: 3555050 [Abstract] [Full Text] [Related]
26. [Importance and administration of beta-lactam antibiotics in practice]. Kienitz M. Med Welt; 1982 Aug 13; 33(31-32):1102-4. PubMed ID: 7132655 [No Abstract] [Full Text] [Related]
28. Appropriate use of antibiotics: why should we care? Waldman RH. W V Med J; 1981 Sep 13; 77(9):229-34. PubMed ID: 6948471 [No Abstract] [Full Text] [Related]
29. [Faulty use of antibiotics and the development of resistance]. Daschner F. Internist (Berl); 1988 May 13; 29(5):345-6. PubMed ID: 3042676 [No Abstract] [Full Text] [Related]
30. Community-acquired lower respiratory tract infections: clinical experience with beta-lactam/beta-lactamase inhibitors. Lode H. Int J Clin Pract Suppl; 2002 Mar 13; (125):10-17; discussion 37-9. PubMed ID: 12014852 [Abstract] [Full Text] [Related]
31. [Mechanisms of resistance to beta-lactam inhibitors of beta-lactamases]. Blázquez J. Rev Esp Quimioter; 1998 Dec 13; 11(4):368-9. PubMed ID: 10336318 [No Abstract] [Full Text] [Related]
32. Part II. Introduction to the beta-lactam antibiotics. Cooper TW, Gibbs WJ, Bronze MS, Greenfield RA. J Okla State Med Assoc; 2006 Oct 13; 99(10):516-20. PubMed ID: 17125105 [No Abstract] [Full Text] [Related]
33. Antimicrobial activity of beta-lactam antibiotics against clinical pathogens after molecular inclusion in several cyclodextrins. A novel approach to bacterial resistance. Athanassiou G, Michaleas S, Lada-Chitiroglou E, Tsitsa T, Antoniadou-Vyza E. J Pharm Pharmacol; 2003 Mar 13; 55(3):291-300. PubMed ID: 12724033 [Abstract] [Full Text] [Related]
34. The role of the newer beta-lactam antibiotics in the treatment of infection in compromised hosts. Greene WH. Bull N Y Acad Med; 1984 May 13; 60(4):426-38. PubMed ID: 6372918 [No Abstract] [Full Text] [Related]
35. Antimicrobial drug therapy. Braude AI. Major Probl Intern Med; 1976 May 13; 8():111-218. PubMed ID: 772325 [No Abstract] [Full Text] [Related]
36. [What is the role of clinical pharmacology in the present-day selection of antibacterial antibiotics?]. Chruściel TL. Przegl Lek; 1984 May 13; 41(4):347-50. PubMed ID: 6379756 [No Abstract] [Full Text] [Related]
37. [Enterococcal resistance to beta-lactam and aminoglycoside antibiotics]. Liñares Louzao J, Ayats Ardite J, Alonso Figueres T. Rev Clin Esp; 1995 Oct 13; 195 Suppl 4():16-21. PubMed ID: 9441311 [No Abstract] [Full Text] [Related]
38. Beta-lactams with or without aminoglycosides. Alfandari S, Boussekey N. Clin Infect Dis; 2005 Nov 15; 41(10):1542-3; author reply 1543-4. PubMed ID: 16231273 [No Abstract] [Full Text] [Related]
39. Resilient bacteria making our antibiotics ineffective. Can Oper Room Nurs J; 1987 Feb 15; 5(1):6-9. PubMed ID: 3644692 [No Abstract] [Full Text] [Related]